WO2005087793A3 - Immunostimulatory compositions and uses thereof - Google Patents
Immunostimulatory compositions and uses thereof Download PDFInfo
- Publication number
- WO2005087793A3 WO2005087793A3 PCT/US2005/003766 US2005003766W WO2005087793A3 WO 2005087793 A3 WO2005087793 A3 WO 2005087793A3 US 2005003766 W US2005003766 W US 2005003766W WO 2005087793 A3 WO2005087793 A3 WO 2005087793A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- immunostimulatory compositions
- immunostimulatory
- compositions
- identification
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/588,627 US8034773B2 (en) | 2004-02-05 | 2005-02-04 | Immunostimulatory compositions and uses thereof |
US13/270,010 US10093712B2 (en) | 2004-02-05 | 2011-10-10 | Immunostimulatory compositions and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54219804P | 2004-02-05 | 2004-02-05 | |
US60/542,198 | 2004-02-05 | ||
US63382504P | 2004-12-07 | 2004-12-07 | |
US60/633,825 | 2004-12-07 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/588,627 A-371-Of-International US8034773B2 (en) | 2004-02-05 | 2005-02-04 | Immunostimulatory compositions and uses thereof |
US13/270,010 Continuation US10093712B2 (en) | 2004-02-05 | 2011-10-10 | Immunostimulatory compositions and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005087793A2 WO2005087793A2 (en) | 2005-09-22 |
WO2005087793A3 true WO2005087793A3 (en) | 2006-06-29 |
Family
ID=34971742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/003766 WO2005087793A2 (en) | 2004-02-05 | 2005-02-04 | Immunostimulatory compositions and uses thereof |
Country Status (2)
Country | Link |
---|---|
US (2) | US8034773B2 (en) |
WO (1) | WO2005087793A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034773B2 (en) | 2004-02-05 | 2011-10-11 | Arizona Biomedical Research Commission | Immunostimulatory compositions and uses thereof |
WO2006063028A2 (en) * | 2004-12-07 | 2006-06-15 | The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University | Immunostimulatory compositions and uses thereof |
USRE46425E1 (en) * | 2006-12-13 | 2017-06-06 | Susavion Biosciences, Inc. | Pro-angiogenic peptides and uses thereof |
US7838497B2 (en) * | 2006-12-13 | 2010-11-23 | Susavion Biosciences, Inc. | Pro-angiogenic peptides |
US8460697B2 (en) | 2006-12-13 | 2013-06-11 | Susavion Biosciences, Inc. | Pro-angiogenic peptides and uses thereof |
US7811995B2 (en) * | 2006-12-13 | 2010-10-12 | Susavion Biosciences, Inc. | Therapeutic and diagnostic peptides |
US8496942B2 (en) | 2006-12-13 | 2013-07-30 | Susavion Biosciences, Inc. | Therapeutic peptides and uses thereof |
WO2011027308A1 (en) * | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
AU2012240945B2 (en) * | 2011-04-07 | 2017-03-16 | Efranat Ltd. | Macrophage activating factor for pharmaceutical compositions |
EP2819749A4 (en) * | 2012-03-01 | 2016-03-02 | Univ Columbia | Autism-associated biomarkers and uses thereof |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
EP3233104B1 (en) * | 2014-12-19 | 2020-03-04 | Susavion Biosciences, Inc. | Immunotherapy treatments and compositions |
JP6740250B2 (en) * | 2015-04-27 | 2020-08-12 | スサヴィオン バイオサイエンシーズ インコーポレイテッド | Compositions and methods for treating cancer and persistent viral infections |
US10350260B2 (en) * | 2015-04-27 | 2019-07-16 | Susavion Biosciences, Inc. | Compositions and methods for treating cancer and persistent viral infections |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040903A1 (en) * | 1995-06-07 | 1996-12-19 | Nobuto Yamamoto | Macrophage activating factors derived from cloned vitamin d binding protein |
US5641747A (en) * | 1994-07-25 | 1997-06-24 | Temple University-Of The Commonwealth System Of Higher Education | Treatment of osteopetrotic diseases |
WO2000031130A1 (en) * | 1998-11-20 | 2000-06-02 | Bio Merieux | Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications |
WO2002058589A2 (en) * | 2000-11-09 | 2002-08-01 | Northeastern Ohio Universities College Of Medicine | Agents and methods for promoting bone growth |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100295038B1 (en) | 1993-03-08 | 2001-09-17 | 후지야마 아키라 | Novel L-sorbosdehydrogenase and L-sorbosone dehydrogenase obtained from Gluconobacter oxydans T-100 |
DE4407489A1 (en) | 1994-03-07 | 1995-09-14 | Bayer Ag | Vaccine for the prevention of respiratory and reproductive diseases of the pig |
US6489541B1 (en) | 1994-06-24 | 2002-12-03 | Michigan State University Board Of Trustees | Genetic control of plant hormone levels and plant growth |
RU2218348C2 (en) | 1994-07-05 | 2003-12-10 | Стено Рисерч Груп А/С | Polypeptide with il-10-similar property (variant), polypeptide conjugate, pharmaceutical composition, method for modulation of immune response in mammal |
US5677276A (en) | 1994-12-23 | 1997-10-14 | La Jolla Cancer Research Foundation | Immobilization of peptides to hyaluronate |
GB9714680D0 (en) | 1997-07-11 | 1997-09-17 | Medical Res Council | Recombinant production of proteins |
US5891994A (en) | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
US6180343B1 (en) * | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
US7105481B2 (en) | 1998-11-10 | 2006-09-12 | Ludwig Institute For Cancer Research | Method for stimulating connective tissue growth or wound healing |
US20040031072A1 (en) | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
CA2290722A1 (en) | 1999-12-08 | 2001-06-08 | Glen C. Macdonald | Consensus peptide presenting entities |
US20110131679A2 (en) | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US7202226B2 (en) | 2000-10-23 | 2007-04-10 | Detroit R & D | Augmentation of wound healing by elF-4E mRNA and EGF mRNA |
GB0112126D0 (en) | 2001-05-18 | 2001-07-11 | Allergene Inc | Composition |
WO2003061589A2 (en) | 2002-01-23 | 2003-07-31 | Cel-Sci Corporation | Methods for treating diseases or conditions with peptide constructs |
ES2335485T3 (en) | 2002-01-25 | 2010-03-29 | The University Court Of The University Of Aberdeen | PEPTIDES AND NUCLEIC ACIDS OF THE CATELICIDINE FAMILY, DERIVATIVES OF FISH, AND USES OF THE SAME. |
WO2003078962A2 (en) | 2002-03-11 | 2003-09-25 | President And Fellows Of Harvard College | Detection and quantification of modified proteins |
EP1499724B1 (en) * | 2002-04-18 | 2013-05-22 | Yeda Research And Development Co., Ltd. | Derivatives of the il-2 receptor gamma chain, their production and use |
WO2003091275A2 (en) | 2002-04-23 | 2003-11-06 | Andrea Savarino | Compositions containing anti-hiv peptides and methods of use |
US7528223B2 (en) | 2002-07-24 | 2009-05-05 | Intercell Ag | Antigens encoded by alternative reading frames from pathogenic viruses |
US7462593B2 (en) | 2002-11-07 | 2008-12-09 | Us Gov Health & Human Serv | Compositions and methods for promoting angiogenesis |
WO2005017133A1 (en) | 2003-08-18 | 2005-02-24 | Amsterdam Institute Of Viral Genomics B.V. | Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
US20050063937A1 (en) | 2003-09-16 | 2005-03-24 | Cheng Li | Multiple-arm peptide compounds, methods of manufacture and use in therapy |
US8034773B2 (en) | 2004-02-05 | 2011-10-11 | Arizona Biomedical Research Commission | Immunostimulatory compositions and uses thereof |
JP2008522951A (en) | 2004-07-19 | 2008-07-03 | ベイラー・カレツジ・オブ・メデイシン | Regulation of cytokine signaling regulators and application for immunotherapy |
US20060078535A1 (en) | 2004-10-13 | 2006-04-13 | The Regents Of The University Of Michigan | Anticancer compounds and methods |
WO2006063028A2 (en) | 2004-12-07 | 2006-06-15 | The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University | Immunostimulatory compositions and uses thereof |
DK2343320T3 (en) | 2005-03-25 | 2018-01-29 | Gitr Inc | ANTI-GITR ANTIBODIES AND APPLICATIONS THEREOF |
EP1904094A2 (en) | 2005-06-17 | 2008-04-02 | Genentech, Inc. | Use of vegf for wound healing |
US20070154448A1 (en) | 2005-11-22 | 2007-07-05 | Ted Reid | Methods and compositions using Substance P to promote wound healing |
-
2005
- 2005-02-04 US US10/588,627 patent/US8034773B2/en active Active
- 2005-02-04 WO PCT/US2005/003766 patent/WO2005087793A2/en active Application Filing
-
2011
- 2011-10-10 US US13/270,010 patent/US10093712B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641747A (en) * | 1994-07-25 | 1997-06-24 | Temple University-Of The Commonwealth System Of Higher Education | Treatment of osteopetrotic diseases |
WO1996040903A1 (en) * | 1995-06-07 | 1996-12-19 | Nobuto Yamamoto | Macrophage activating factors derived from cloned vitamin d binding protein |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
WO2000031130A1 (en) * | 1998-11-20 | 2000-06-02 | Bio Merieux | Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications |
WO2002058589A2 (en) * | 2000-11-09 | 2002-08-01 | Northeastern Ohio Universities College Of Medicine | Agents and methods for promoting bone growth |
Non-Patent Citations (1)
Title |
---|
DATABASE PSIPS [online] USPTO; 18 October 2005 (2005-10-18), XP002349772, retrieved from HTTP://SEQDATA.USPTO.GOV/?PAGEREQUEST=VIEWSEQUENCE&DOCID=06551795&SEQID=27024 * |
Also Published As
Publication number | Publication date |
---|---|
US20120108521A1 (en) | 2012-05-03 |
US8034773B2 (en) | 2011-10-11 |
US10093712B2 (en) | 2018-10-09 |
US20090041793A1 (en) | 2009-02-12 |
WO2005087793A2 (en) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
WO2006066024A8 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
WO2007133290A8 (en) | Anti-ox40l antibodies and methods using same | |
WO2006017538A3 (en) | Hk1-binding proteins | |
WO2007014930A3 (en) | Polyammonium/polysiloxane copolymers | |
WO2008121767A3 (en) | Stitched polypeptides | |
WO2008060705A3 (en) | Anti-dll4 antibodies and methods using same | |
WO2007136893A3 (en) | Anti-fgf19 antibodies and methods using same | |
WO2006079076A3 (en) | Yersinia spp. polypeptides and methods of use | |
WO2006060513A3 (en) | Toll like receptor 3 antagonists, methods and uses | |
WO2007130697A3 (en) | Anti-ephb4 antibodies and methods using same | |
WO2007051164A3 (en) | Toll like receptor 3 modulators, methods and uses | |
WO2009058564A3 (en) | Immunosuppressive polypeptides and nucleic acids | |
EP1578930A4 (en) | Cngh0004 polypeptides, antibodies, compositions, methods and uses | |
WO2006063028A3 (en) | Immunostimulatory compositions and uses thereof | |
WO2007053512A3 (en) | Novel protein transduction domains and uses therefor | |
WO2007076370A3 (en) | Block copolymer particles | |
WO2005047545A3 (en) | Microarray controls | |
WO2007127506A3 (en) | Anti-ephrinb2 antibodies and methods using same | |
WO2006091848A3 (en) | Isolated bis-linezolid, preparation thereof, and its use as a reference standard | |
EP1617802A4 (en) | Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
MY163037A (en) | Endoparasiticidal compositions | |
WO2006050458A3 (en) | Tadalafil crystal forms and processes for preparing them | |
WO2006127368A3 (en) | Methods for synthesizing imidazotriazinones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10588627 Country of ref document: US |